BR3 Agrobiotecnologia is a biotechnology company based in Sao Paulo, Brazil, known for its Mosquito Larvicide product DengueTech. The product, developed in conjunction with FioCruz, is focused on eradicating the Aedes Aegypti Mosquito, the vector for Dengue, Zika, and Chikungunya. Founded in 2001, BR3 Agrobiotecnologia operates in the industries of Biotechnology, Design, and Health Care. The company secured a BRL1.00M Series A investment on 01 August 2009, with participation from SP Ventures and Criatec Fund.
No recent news or press coverage available for BR3 Agrobiotecnologia.